‘Hospitals Must Assess Patients for Thrombosis’

On 06/Nov/2019 / In Medical News

A Professor of Haematology at the University of Benin Teaching Hospital, Dr Omolade Awodu, has advised hospitals to always check the patients they admit for symptoms of thrombosis.
Speaking at the unveiling of a health product produced by Sanofi and known as Clexane, Awodu said,“It is not just enough to admit a patient, the hospital should be able to assess if the patient is at risk and should be placed on prophylaxis. “Thrombosis has been identified as one of the leading causes of death in the country, especially blood clot-related death. Pregnancy increases the risk of this condition, but the good thing is that it is preventable. When we talk about prophylaxis, it is a kind of medication used to prevent the occurrence of an illness. Studies have shown that thrombosis is 90 per cent preventable. So, there is the need to give thrombo prophylaxis to patients in the hospitals.
The General Manager and Country Director for Sanofi, Nigeria and Ghana, Ms. Folake Odediran, said, “What we are doing is a response to an urgent need within the medical community. Over the years, we have collaborated with health care providers. In line with our purpose of identifying the health care needs and solving it, we don’t just try to promote our products; we try to understand what the concerns are.”

CLICK HERE TO ATTEND: Offshore/ Onshore Medic HSE Certificate Course for Doctors, Nurses, Paramedics and Healthcare Professionals


Join the Medicalworld Nigeria Telegram group for latest Medical updates, news and jobs!!

Download Our Official App